Literature DB >> 17514014

The relation between symptoms, viral load, and viral load set point in primary HIV infection.

Colleen F Kelley1, Jason D Barbour, Frederick M Hecht.   

Abstract

OBJECTIVES: To examine the relation between symptoms, initial viral load, and viral load set point in primary HIV infection (PHI).
DESIGN: Prospective cohort of patients with preseroconversion or recent seroconversion HIV infection (typically <60 days) in San Francisco.
METHODS: Subjects were questioned about 21 potential PHI symptoms at enrollment and were subsequently followed with viral load measures.
RESULTS: The analysis included 57 subjects with preseroconversion HIV infection and 120 with recent seroconversion. In univariate analysis, most symptoms and the total number of symptoms were each associated with a significantly higher initial viral load. In stepwise multiple linear regression, however, only the number of symptoms was independently associated with a higher initial viral load, with an increase in the initial viral load of 0.08 log10 per additional symptom (P < 0.001). In univariate analysis, more PHI symptoms were associated with a higher viral load set point, but in a multivariable mixed-effects model, this association was accounted for by the initial viral load, which was strongly correlated with viral load set point (R = 0.44, P < 0.001).
CONCLUSIONS: A high initial viral load was associated with more symptoms during PHI. The strong correlation between initial HIV-1 RNA viral load levels and viral load set point suggests that early interactions between the HIV-1 virus and a new host, even before fully developed adaptive immune responses, are important in establishing viral load set point.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514014     DOI: 10.1097/QAI.0b013e318074ef6e

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  36 in total

1.  The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease.

Authors:  Jennifer E Ho; Rebecca Scherzer; Frederick M Hecht; Kristinalisa Maka; Van Selby; Jeffrey N Martin; Peter Ganz; Steven G Deeks; Priscilla Y Hsue
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

Review 2.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

3.  A Simple Symptom Score for Acute Human Immunodeficiency Virus Infection in a San Diego Community-Based Screening Program.

Authors:  Timothy C Lin; Sara Gianella; Tara Tenenbaum; Susan J Little; Martin Hoenigl
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

4.  Transcriptional network predicts viral set point during acute HIV-1 infection.

Authors:  Hsun-Hsien Chang; Kelly Soderberg; Jason A Skinner; Jacques Banchereau; Damien Chaussabel; Barton F Haynes; Marco Ramoni; Norman L Letvin
Journal:  J Am Med Inform Assoc       Date:  2012-06-14       Impact factor: 4.497

5.  Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.

Authors:  Jennifer E Ho; Steven G Deeks; Frederick M Hecht; Yu Xie; Amanda Schnell; Jeffrey N Martin; Peter Ganz; Priscilla Y Hsue
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

6.  Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Authors:  Merlin L Robb; Leigh A Eller; Hannah Kibuuka; Kathleen Rono; Lucas Maganga; Sorachai Nitayaphan; Eugene Kroon; Fred K Sawe; Samuel Sinei; Somchai Sriplienchan; Linda L Jagodzinski; Jennifer Malia; Mark Manak; Mark S de Souza; Sodsai Tovanabutra; Eric Sanders-Buell; Morgane Rolland; Julie Dorsey-Spitz; Michael A Eller; Mark Milazzo; Qun Li; Andrew Lewandowski; Hao Wu; Edith Swann; Robert J O'Connell; Sheila Peel; Peter Dawson; Jerome H Kim; Nelson L Michael
Journal:  N Engl J Med       Date:  2016-05-18       Impact factor: 91.245

7.  Community viral load as a measure for assessment of HIV treatment as prevention.

Authors:  William C Miller; Kimberly A Powers; M Kumi Smith; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2013-03-25       Impact factor: 25.071

8.  Host genetics and HIV-1 viral load set-point in African-Americans.

Authors:  Sadeep Shrestha; Brahim Aissani; Wei Song; Craig M Wilson; Richard A Kaslow; Jianming Tang
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

9.  Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.

Authors:  Paul Volberding; Lisa Demeter; Ronald J Bosch; Evgenia Aga; Carla Pettinelli; Martin Hirsch; Mary Vogler; Ana Martinez; Susan Little; Elizabeth Connick
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

10.  Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands.

Authors:  Luuk Gras; Suzanne Jurriaans; Margreet Bakker; Ard van Sighem; Daniela Bezemer; Christophe Fraser; Joep Lange; Jan M Prins; Ben Berkhout; Frank de Wolf
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.